The landscape of dementia diagnosis has evolved drastically with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based mostly exams that may detect Alzheimer's pathology years before indications arise. Although these technological developments represent extraordinary progress in knowing neurodegenerative diseases, they may have not diminished https://sandraz096cmx7.wikihearsay.com/user